Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope-Reference-Cited by-同舟云学术

Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope

Published:2009-08-20 Issue:9 Volume:11 Page:881-886
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Phan Thanh Trung¹,Shivu Ganesh Nallur¹,Choudhury Anirban²,Abozguia Khalid¹,Davies Chris¹,Naidoo Ulasini¹,Ahmed Ibrar¹,Yousef Zaheer²,Horowitz John³,Frenneaux Michael¹

Affiliation:

1. Department of Cardiovascular Medicine; University of Birmingham; Birmingham B15 2TT UK

2. University Hospital of Wales; Cardiff UK

3. The Queen Elizabeth Hospital; University of Adelaide; Woodville South Australia 5011 Australia

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfp106/fullpdf

Reference25 articles.

1. Prognosis of patients with heart failure compared with common types of cancer;Stewart;Heart Fail Monit,2003

2. Heart failure;Jessup;N Engl J Med,2003

3. Heart failure therapy at a crossroad: are there limits to the neurohormonal model?;Mehra;J Am Coll Cardiol,2003

4. The medical treatment of angina pectoris;Chamberlain;Br Heart J,1987

5. The heart metabolism: pathophysiological aspects in ischaemia and heart failure;Abozguia;Curr Pharm Des,2009

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular targets for the treatment of angina pectoris;Nanotechnology Principles in Drug Targeting and Diagnosis;2023

2. Perhexiline Therapy in Patients with Type 2 Diabetes: Incremental Insulin Resistance despite Potentiation of Nitric Oxide Signaling;Biomedicines;2022-09-23

3. Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients;Frontiers in Cardiovascular Medicine;2021-12-22

4. Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer;Cell Reports Medicine;2021-12

5. Electrophysiological and ECG Effects of Perhexiline, a Mixed Cardiac Ion Channel Inhibitor, Evaluated in Nonclinical Assays and in Healthy Subjects;The Journal of Clinical Pharmacology;2021-07-20